Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-20 · accession 0001415889-22-009867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-22 | 2022-09-20 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $55.00 | -1,176 | 61.1K | -2% | -$64.7K |
| DM | 2022-09-22 | 2022-09-20 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $30.86 | +1,176 | 61.4K | +2% | +$36.3K |
| DM | 2022-09-22 | 2022-09-20 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $30.86 | -1,176 | 69.1K | -2% | -$36.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-20 | S | D | 876 | $55.00 | 61,110 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-20 | S | D | 300 | $55.00 | 61,110 | D | — | — | |
| 3 | Common | Common Stock | 2022-09-20 | M | A | 876 | $30.86 | 61,986 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-20 | M | A | 300 | $30.86 | 61,410 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-09-20 | M | D | 300 | $30.86 | 68,824 | D | $30.86 · — to 2026-01-03 | 69,124 Common Stock | (F2) Currently exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-09-20 | M | D | 876 | $30.86 | 69,124 | D | $30.86 · — to 2026-01-03 | 70,000 Common Stock | (F2) Currently exercisable. |